O-104 Two Year Outcomes Of Children Treated With Dextrose Gel For Neonatal Hypoglycaemia: Follow Up Of A Randomised Trial

Background Neonatal hypoglycaemia is linked to poor developmental outcome. Dextrose gel reverses hypoglycaemia, but its long term effects are unknown. Aim To determine two year outcomes of children randomised to dextrose or placebo gel for treatment of neonatal hypoglycaemia1. Methods At risk babies...

Full description

Saved in:
Bibliographic Details
Published inArchives of disease in childhood Vol. 99; no. Suppl 2; pp. A64 - A65
Main Authors Harris, DL, Weston, PJ, Alsweiler, JM, Thompson, B, Wouldes, T, Chase, G, Jiang, Y, Gamble, G, Harding, JE
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group LTD 01.10.2014
Subjects
Birth weight
Body Weight
Cerebral Palsy
Children
Cognitive ability
Dextrose
Evidence-based medicine
Executive function
Gestation
Hypoglycemia
Language
Long-term effects
Motion detection
Motor skill
Neonates
Newborn babies
Paralysis
Perception
Pregnancy
Sugar
Online AccessGet full text

Cover

More Information
Summary:Background Neonatal hypoglycaemia is linked to poor developmental outcome. Dextrose gel reverses hypoglycaemia, but its long term effects are unknown. Aim To determine two year outcomes of children randomised to dextrose or placebo gel for treatment of neonatal hypoglycaemia1. Methods At risk babies who became hypoglycaemic (<2.6 mM) were randomised to 40% dextrose or placebo gel. Children were assessed at two years’ corrected age for neurological function and general health (paediatrician assessed); cognitive, language, behaviour and motor skills (Bayley III); executive function; and vision (clinical examination and global motion perception). Primary outcomes were neurosensory disability (cognitive, language or motor score below -1 SD or cerebral palsy or blind or deaf) and processing problem (executive function or global motion perception worse than 1.5 SD). Data are mean (SD), n (%), or relative risk (RR), 95% confidence interval. Results 184 children were assessed; 90/118 (76%) randomised to dextrose and 94/119 (79%) to placebo gel. Mean birth weight was 3093 (803) g and gestation 37.7 (1.6) wk. 67 children (36%) had neurosensory disability (1 severe, 9 moderate, 57 mild) with similar rates in both groups (dextrose 35 (39%) vs placebo 32 (34%), RR 1.14, 0.78–1.67). Processing difficulty was also similar in both groups (dextrose 8 (10%) vs placebo 16 (18%), RR 0.52, 0.23–1.15). Discussion Neurosensory disability is common amongst children treated for neonatal hypoglycaemia. Treatment with dextrose gel does not change the incidence of disability or processing problems. Reference Harris DL, et al. Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study). Lancet 2013;382:2077–83
ISSN:0003-9888
1468-2044
DOI:10.1136/archdischild-2014-307384.171